Cyxtera Investor Presentation Deck

CONFIDENTIAL Disclaimer This Cleansing Presentation (this "Presentation") contains forward-looking information within the meaning of the U.S. federal securities laws, including, without limitation, financial projections and other estimates (collectively, the "Projections") with respect to the anticipated performance of Cyxtera Technologies, Inc. (the "Company"). Those statements include statements regarding the intent, belief or current expectations of the Company and members of its management team, as well as the assumptions on which such statements are based, and generally are identified by the use of words such as "may," "will," "seeks," "anticipates," "believes," "estimates," "expects," "plans," "intends," "should" or similar expressions. The Projections have been prepared in good faith based upon assumptions that the Company believes to be reasonable as of the date on the cover of this Presentation, it being understood that the Projections are as to future events and are not to be viewed as facts, that the Projections are subject to significant uncertainties and contingencies, many of which are beyond the Company's control, that no assurance can be given that any particular Projections will be realized and that actual results during the period or periods covered by any such Projections may differ significantly from the projected results and such differences may be material. You should reference the "Risk Factors" included in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC") from time to time for a discussion of the significant risks, uncertainties and contingencies involving the Company. In addition, the Projections were not prepared with a view to public disclosure or compliance with published guidelines of the SEC, the guidelines established by the Public Company Accounting Oversight Board or U.S. generally accepted accounting principles ("GAAP") or any other applicable accounting principles. The information used to prepare, and contained in, this Presentation is based upon industry, business, financial, legal, regulatory, tax, accounting, actuarial and other information (including, without limitation, Projections) furnished by the Company or information otherwise obtained from public sources, data suppliers and other third parties. The information in this Presentation was prepared by the Company for informational purposes only, and neither the Company or any of its direct or indirect equity holders or affiliates or any of their or their affiliates' respective partners, directors, officers, employees, agents, advisors and other representatives (collectively, with respect to any person or entity, the "Representatives"), bears any responsibility, obligation or liability relating to or arising from, or for the accuracy or completeness (or lack thereof) of, any of the information in this Presentation. No representation, guaranty or warranty (express or implied) regarding this Presentation or as to the accuracy or completeness of any of the information therein, including without limitation any Projections (or any assumptions underlying them, the Company's future operations or the amount of any future income or loss), is made by the Company or any of its affiliates or their (or their affiliates') respective Representatives. Neither the Company or any of its direct or indirect equity holders or affiliates or any of their (or their affiliates') respective Representatives shall have any obligation to update, correct or supplement this Presentation or otherwise provide additional information in connection herewith or any other matter (it being understood that this Presentation speaks only as of the date hereof), and neither the delivery of this Presentation shall, under any circumstances, imply that the information contained herein is correct as of any future date or that there has been no change in the affairs of the Company after the date hereof. This Presentation includes Transaction Adjusted EBITDA and other non-GAAP financial measures. The Company defines Transaction Adjusted EBITDA as net income (loss) before the following items: depreciation and amortization; interest and other expenses, net; income tax expense (benefit); equity-based compensation; stand-up separation and other; restructuring costs and other; straight-line rent adjustment; amortization of favorable / unfavorable leasehold interest and asset retirement obligation accretion; change in fair value of warrant liabilities; transaction-related costs and impairment of note and other receivables from an affiliate. Please see the Appendix to this Presentation for a reconciliation of net loss to Transaction Adjusted EBITDA. The non-GAAP measures provided herein may not be directly comparable to similar measures used by other companies in the Company's industry, as other companies may define such measures differently. The non-GAAP measures presented herein are not measurements of financial performance under GAAP, and should not be considered as alternatives to, and should only be considered together with, the Company's financial results in accordance with GAAP. The Company does not consider these non-GAAP financial measures to be a substitute for, or superior to, the information provided by GAAP financial results. The Company does not provide a forward-looking reconciliation of certain forward-looking non-GAAP measures as the amount and significance of special items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These special items could be meaningful. Cyxtera N

View entire presentation